Which coronavirus disease 2019 (COVID-19) vaccines are likely to be available first?

Updated: Feb 28, 2021
  • Author: David J Cennimo, MD, FAAP, FACP, AAHIVS; more...
  • Print


On February 27, 2021, The US Food and Drug Administration (FDA) granted Johnson & Johnson for an Emergency Use Authorization (EUA) for its single dose Ad26.COV2.S vaccine. The independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously (22 to 0) in favor to recommend the EUA. 

On December 18, 2020, the FDA granted EUA for the mRNA-1273 SARS-CoV-2 vaccine in individuals 18 years and older, after the VRBPAC voted to recommend (20 yes, 0 no, 1 abstention) the EUA on December 17. 

On December 11, 2020, the FDA granted EUA for the BNT-162b2 SARS-CoV-2 vaccine in patients 16 years and older on December 11, 2020, after its VRBPAC voted to recommend (17 yes, 4 no, 1 abstention) the EUA on December 10. 

ACIP has published guidelines on the ethical principles for the initial allocation for this scarce resource. [2]  

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!